Appva AB provides the product Medication and Care Support System, MCSS – a mobile and digital signature app for medication tracking in the municipal health and care system. The product was launched in 2012 and is used by about 100 customers in Sweden, most of which are municipal administrations.
MCSS offers customers an array of functions that facilitate modern working methods. Health personnel can use a tablet, smartphone or computer to record and sign off on medications administered to patients, along with a secure and reliable method for recording each health procedure.
Payment will be in cash and by way of a convertible, with waiver of the shareholders’ preferential rights as authorised in a Shareholders’ Meeting on 10 April 2019. The convertible matures in 36 months and will at full conversion have a 0.1% dilutive effect on capital. The acquisition is expected to directly increase earnings per share for Vitec. Consolidation will take place as at the acquisition date.